Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.64 |
| ▸ | CES1 | P23141 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30485086 | 1.00 | CES2 (0.64) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL2562024 | 1.00 | CES2 (0.64) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL9046982 | 1.00 | CES2 (0.64) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL9340459 | 0.86 | CES2 (0.61) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL8292394 | 0.86 | CES2 (0.61) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL21990664 | 0.85 | CES2 (0.64) | CES2CES1PSMB5 | |
| SCHEMBL13580704 | 0.85 | CES2 (0.64) | CES2CES1PSMB5 | |
| SCHEMBL7804388 | 0.85 | CES2 (0.59) | CES2CES1ALDH1A1MAPK14L3MBTL1 | |
| SCHEMBL30485128 | 0.85 | CES2 (0.64) | CES2CES1PSMB5 | |
| SCHEMBL2563657 | 0.85 | CES2 (0.64) | CES2CES1PSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1535914-B1 | PROCESSES FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL CO (JP) | 2011-11-02 | — | — | EP | claimed |
| US-7297802-B2 | Production methods of epoxytriazole derivative and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-11-20 | — | — | US | claimed |
| EP-1535914-A1 | PROCESSES FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE AND INTERMEDIATE THEREFOR | Sumitomo Chemical Company, Limited (JP) | 2005-06-01 | — | — | EP | claimed |
| US-6884892-B2 | Production methods of epoxytriazole derivative and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-04-26 | — | — | US | claimed |
| US-20040267024-A1 | Production methods of epoxytriazole derivative and intermediate therefor | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2004-12-30 | — | — | US | claimed |
| US-20030236419-A1 | Production methods of epoxytriazole derivative and intermediate therefor | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2003-12-25 | — | — | US | claimed |
| US-5426233-A | Contacting dihalophenone type compound with chiral hydroxylating compound at low temperature | SCHERING CORPORATION (US) | 1995-06-20 | — | — | US | claimed |
| WO-1992017433-A1 | PREPARATION OF CHIRAL HYDROXYKETONES | SCHERING CORPORATION (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0506341-A1 | Preparation of chiral hydroxyketones | SCHERING CORPORATION (US) | 1992-09-30 | — | — | EP | claimed |
| CN-110997646-B | Process for producing epoxy alcohol compound | 住友化学株式会社 | 2023-06-20 | — | — | CN | disclosed |
| EP-3666762-B1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-04-06 | — | — | EP | disclosed |
| US-10730861-B2 | Process for producing epoxy alcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| EP-3666762-A1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-06-04 | — | — | US | disclosed |
| US-5405861-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, CO., LTD. (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0332387-B1 | Triazole derivatives, their preparation and their use as fungicides | SANKYO CO (JP) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992017433-A1 | PREPARATION OF CHIRAL HYDROXYKETONES | SCHERING CORPORATION (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0506341-A1 | Preparation of chiral hydroxyketones | SCHERING CORPORATION (US) | 1992-09-30 | — | — | EP | disclosed |
| EP-0421210-A2 | Triazole compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |
| EP-0332387-A1 | Triazole derivatives, their preparation and their use as fungicides | Sankyo Company Limited (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267024-A1 | Production methods of epoxytriazole derivative and intermediate therefor | ERG28, CYP51A1, SOAT2 | CES2 3927/4885CES1 981/4885ALDH1A1 967/4885 |
| US-20030236419-A1 | Production methods of epoxytriazole derivative and intermediate therefor | ERG28, CYP51A1, SOAT2 | CES2 3927/4885CES1 981/4885ALDH1A1 967/4885 |
| US-20200172520-A1 | PROCESS FOR PRODUCING EPOXY ALCOHOL COMPOUND | ERG28, CYP2E1, ADH5 | CES2 1409/4885CES1 776/4885ALDH1A1 501/4885 |
| US-10730861-B2 | Process for producing epoxy alcohol compound | ERG28, CYP2E1, ADH5 | CES2 1409/4885CES1 776/4885ALDH1A1 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.